Hudson CEO appointed to NHMRC Council
Hudson Institute of Medical Research Director and CEO Professor Elizabeth Hartland has been appointed to the Council of the National Health and Medical Research Council (NHMRC).
Professor Hartland will join 12 other leading medical researchers, academics, clinicians and administrators on the Council. Her 3-year term begins immediately, and she joins a distinguished group entrusted with the responsibility of guiding Australians’ current and future health.
“This is clearly a crucial time for the medical sector,” Professor Hartland said.
“It has never been more important to ensure that Australians have access to authoritative, evidence-based health advice.”
Professor Hartland is an international leader in the field of microbiology and immunology who brings a wealth of experience to the role beyond her specialty area of microbial drug resistance.
She has held a Royal Society/NHMRC Howard Florey Fellowship in the Department of Biochemistry, Imperial College London and Lecturer/Senior Lecturer positions at Monash University.
As well as her role at Hudson Institute, which she has held since 2017, Professor Hartland is Head of the Department of Molecular and Translational Science at Monash University.
“As the nation’s leading expert body in health and medical research, the NHMRC has a proud history of serving and protecting Australians; I look forward to the opportunity to play a part in that vital work,” she said.
What factors influence hospital staff retention?
Rather than applying a 'one-size-fits-all' approach, staff retention efforts need to be...
Professor Christine Kilpatrick to lead ACSQHC as Chair
The Australian Commission on Safety and Quality in Health Care has appointed Professor Christine...
Funding boost for on-demand telehealth provider Hola Health
The Pre-Series A venture funding will support the company's mission to provide fast,...
